Browse by Series:

Clinical Hold Lifted in AML, and Encouraging Phase III Findings in Myeloma, CLL, and Breast Cancer

Brielle Uricioli
Published: Friday, Mar 10, 2017



Brielle Uricioli reports on promising phase III findings in breast cancer, chronic lymphocytic leukemia, and multiple myeloma, a clinical hold lifted in AML, and an American Health Care Act replacement released by Republicans.
Slider Left
Slider Right


Brielle Uricioli reports on promising phase III findings in breast cancer, chronic lymphocytic leukemia, and multiple myeloma, a clinical hold lifted in AML, and an American Health Care Act replacement released by Republicans.
View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Oncology Best Practice™: Choosing Therapies for Patients with EGFR-Mutant Lung Cancers: More Options... More Decisions... Better OutcomesFeb 28, 20182.0
Clinical Vignette Series: 34th Annual Chemotherapy Foundation Symposium: Innovative Cancer Therapy for Tomorrow®Feb 28, 20182.0
Publication Bottom Border
Border Publication
x